MedPath

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children

Completed
Conditions
Early Childhood Caries
Registration Number
NCT04958005
Lead Sponsor
Aydin Adnan Menderes University
Brief Summary

This study aimed to evaluate the levels of interleukin 10, interleukin 6, interleukin 32 and tumor necrosis factor-alpha (TNF-α) in saliva of children with early childhood caries.

Detailed Description

Fifty six children ( 28 with early childhood caries and 28 without early childhood caries ; age range 3-6 years) will be recruited for the study. Probing pocket depth (PPD), gingival index (GI) and plaque index (PI) will be recorded and saliva samples will be collected. Interleukin-32, Interleukin-10, Interleukin-6 and TNF-α will be analyzed in saliva samples by ELISA.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Children with untreated early chilhood caries
  • Age between 3 and 6 years
Exclusion Criteria
  • Having a systemic problem or mental retardation
  • Children with treated caries

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IL-32Baseline

Interleukin- 32 level

IL-10Baseline

Interleukin- 10 level

Secondary Outcome Measures
NameTimeMethod
Tnf-AlphaBaseline

Tnf-alpha level

IL-6Baseline

Interleukin- 6 level

Trial Locations

Locations (1)

Sultan KELEŞ

🇹🇷

Aydın, Turkey

Sultan KELEŞ
🇹🇷Aydın, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.